Source:http://linkedlifedata.com/resource/pubmed/id/19222120
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions |
umls-concept:C0015264,
umls-concept:C0017262,
umls-concept:C0185117,
umls-concept:C0205195,
umls-concept:C0392756,
umls-concept:C0441655,
umls-concept:C1029148,
umls-concept:C1420815,
umls-concept:C1511636,
umls-concept:C1551022,
umls-concept:C1704263,
umls-concept:C1961136,
umls-concept:C2717940,
umls-concept:C2911684
|
pubmed:issue |
1
|
pubmed:dateCreated |
2009-2-17
|
pubmed:abstractText |
Hepatocellular carcinoma is a type of tumor highly resistant to available chemotherapeutic agents. The treatment of hepatocellular carcinoma remains a challenge that needs new approaches in the future. In a previous study, we demonstrated that the chloroform fraction (CHCl(3)-F) from Z. jujuba has anticancer activity in human liver cancer cells (HepG2), and that combining CHCl(3)-F with green tea extracts (GTE) results in enhanced effects of anticancer activity in the cells. To further understand the mechanism of the anticancer activity of combining CHCl(3)-F and GTE in HepG2 cells, we investigated whether the addition of a mixture of CHCl(3)-F and GTE would affect the expression of APRIL (a proliferation-inducing ligand), which was expressed in HepG2 cells from 4 hours of incubation in vitro. We have shown that CHCl(3)-F and GTE enhanced anti-cancer activity by reducing the expression of APRIL. We speculate that the CHCl(3)-F and GTE mixture might provide a lead to a new drug design to treat hepatocellular carcinoma in the future.
|
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
IM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:issn |
0192-415X
|
pubmed:author | |
pubmed:issnType |
Print
|
pubmed:volume |
37
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
169-79
|
pubmed:meshHeading |
pubmed-meshheading:19222120-Animals,
pubmed-meshheading:19222120-Antineoplastic Agents, Phytogenic,
pubmed-meshheading:19222120-Antineoplastic Combined Chemotherapy Protocols,
pubmed-meshheading:19222120-Camellia sinensis,
pubmed-meshheading:19222120-Carcinoma, Hepatocellular,
pubmed-meshheading:19222120-Cell Cycle,
pubmed-meshheading:19222120-Cell Line, Tumor,
pubmed-meshheading:19222120-Cell Survival,
pubmed-meshheading:19222120-Gene Expression,
pubmed-meshheading:19222120-Humans,
pubmed-meshheading:19222120-Liver Neoplasms,
pubmed-meshheading:19222120-Phytotherapy,
pubmed-meshheading:19222120-Plant Extracts,
pubmed-meshheading:19222120-Rats,
pubmed-meshheading:19222120-Tea,
pubmed-meshheading:19222120-Tumor Necrosis Factor Ligand Superfamily Member 13,
pubmed-meshheading:19222120-Ziziphus
|
pubmed:year |
2009
|
pubmed:articleTitle |
Combination of Zizyphus jujuba and green tea extracts exerts excellent cytotoxic activity in HepG2 cells via reducing the expression of APRIL.
|
pubmed:affiliation |
Department of Food and Human Health Sciences, Graduate School of Human Life Science, Osaka City University, 3-3-138 Sugimoto, Sumiyoshi-ku, Osaka 558-8585, Japan.
|
pubmed:publicationType |
Journal Article,
Research Support, Non-U.S. Gov't
|